Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1976 1
1982 1
1985 1
1995 1
1997 1
2000 1
2012 1
2013 1
2015 1
2020 1
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer's Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis.
Alongi P, Laudicella R, Panasiti F, Stefano A, Comelli A, Giaccone P, Arnone A, Minutoli F, Quartuccio N, Cupidi C, Arnone G, Piccoli T, Grimaldi LME, Baldari S, Russo G. Alongi P, et al. Among authors: giaccone p. Diagnostics (Basel). 2022 Apr 8;12(4):933. doi: 10.3390/diagnostics12040933. Diagnostics (Basel). 2022. PMID: 35453981 Free PMC article.
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
de Salazar A, Dietz J, di Maio VC, Vermehren J, Paolucci S, Müllhaupt B, Coppola N, Cabezas J, Stauber RE, Puoti M, Arenas Ruiz Tapiador JI, Graf C, Aragri M, Jimenez M, Callegaro A, Pascasio Acevedo JM, Macias Rodriguez MA, Rosales Zabal JM, Micheli V, Garcia Del Toro M, Téllez F, García F, Sarrazin C, Ceccherini-Silberstein F; GEHEP-004 cohort, the European HCV Resistance Study Group and the HCV Virology Italian Resistance Network (VIRONET C). de Salazar A, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3349-3358. doi: 10.1093/jac/dkaa304. J Antimicrob Chemother. 2020. PMID: 32772078
A New Preclinical Decision Support System Based on PET Radiomics: A Preliminary Study on the Evaluation of an Innovative 64Cu-Labeled Chelator in Mouse Models.
Benfante V, Stefano A, Comelli A, Giaccone P, Cammarata FP, Richiusa S, Scopelliti F, Pometti M, Ficarra M, Cosentino S, Lunardon M, Mastrotto F, Andrighetto A, Tuttolomondo A, Parenti R, Ippolito M, Russo G. Benfante V, et al. Among authors: giaccone p. J Imaging. 2022 Mar 30;8(4):92. doi: 10.3390/jimaging8040092. J Imaging. 2022. PMID: 35448219 Free PMC article.
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis.
Pavone AM, Benfante V, Giaccone P, Stefano A, Torrisi F, Russo V, Serafini D, Richiusa S, Pometti M, Scopelliti F, Ippolito M, Giannone AG, Cabibi D, Asti M, Vettorato E, Morselli L, Merone M, Lunardon M, Andrighetto A, Tuttolomondo A, Cammarata FP, Verona M, Marzaro G, Mastrotto F, Parenti R, Russo G, Comelli A. Pavone AM, et al. Among authors: giaccone p. Life (Basel). 2024 Mar 20;14(3):409. doi: 10.3390/life14030409. Life (Basel). 2024. PMID: 38541733 Free PMC article.
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.
Normanno N, Rachiglio AM, Lambiase M, Martinelli E, Fenizia F, Esposito C, Roma C, Troiani T, Rizzi D, Tatangelo F, Botti G, Maiello E, Colucci G, Ciardiello F; CAPRI-GOIM investigators. Normanno N, et al. Ann Oncol. 2015 Aug;26(8):1710-4. doi: 10.1093/annonc/mdv176. Epub 2015 Apr 7. Ann Oncol. 2015. PMID: 25851630 Free article. Clinical Trial.
A route to the total synthesis of iso-LTB4 system.
Pirillo D, Gazzaniga A, Leggeri P, Giaccone P, Traverso G. Pirillo D, et al. Among authors: giaccone p. Farmaco Sci. 1985 Apr;40(4):249-52. doi: 10.1002/chin.198539354. Farmaco Sci. 1985. PMID: 2990999
15 results